Search
for
Sort by
Research 181–210 of 1000+
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- The Use of Stromal Vascular Fraction in the Treatment of Male Sexual Dysfunction: A Review of Preclinical and Clinical Studies
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Is polycystic ovary syndrome a sexual conflict? A review
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Modelling androgen synthesis and action during human sexual differentiation
- Mood and Sexual Function in Polycystic Ovary Syndrome
- Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health
- 46, XY Disorder of Sexual Development with Ambiguous Female External Genitalia: A Case Report
- Steroid Hormones of Reproduction and Sexual Development
- Genetic Defects of Female Sexual Differentiation
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Case Report: Secondary syphilitic alopecia following non-penetrative sexual contact: a case of initial misdiagnosis
- Impact of ustekinumab on quality of life and sexual difficulties associated with psoriasis: Results from phase III clinical trials
- Platelet-rich plasma for erectile dysfunction: a review of the current research landscape
- Sexual dysfunction with 5-alpha-reductase inhibitor therapy for androgenetic alopecia: a global propensity score matched retrospective cohort study
- Age-Related Differences for Male-to-Female Transgender Patients Undergoing Gender-Affirming Surgery
- Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride
- Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo
- Sexual transmission of a new emerging dermatophyte: <i>T. Mentagrophytes</i> genotype VII
- Finasteride: suicidality or psychological adverse events
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)